Here’s a story that highlights the delicate balance between player aspirations and team budgets in professional sports: Cade Cavalli and the Washington Nationals have finally settled their salary arbitration case, agreeing to a one-year, $870,000 deal that includes a 2027 team option. But here’s where it gets interesting—this agreement wasn’t just a handshake; it was a strategic compromise that closed the smallest salary gap among the 18 players who couldn’t reach deals on arbitration swap day. When the numbers were exchanged on January 8, Cavalli asked for $900,000, while the Nationals offered $825,000. The $75,000 difference was the narrowest of all, and they ultimately settled on $862,500 for this year—right in the middle. The team option? A hefty $4 million with a $7,500 buyout, adding another layer of intrigue to this deal.
Cavalli, 27, earned this arbitration eligibility after a solid 2022 season where he went 3-1 with a 4.25 ERA in 10 starts—his first taste of regular big league action. His earnings that year were split between a $760,200 major league salary and $370,100 in the minors, totaling $579,832. Drafted 22nd overall in 2020, Cavalli’s journey hasn’t been without hurdles. He made his MLB debut on August 26, 2022, but an arm injury during a 2023 spring training game against the Mets led to Tommy John surgery just a week later. His road to recovery included a minor league rehab assignment starting May 20, 2024, though he only managed three outings totaling 8 1/3 innings.
The 2025 season saw Cavalli climb the ranks, starting at Class A Fredericksburg before promotions to Double-A Harrisburg and Triple-A Rochester. He returned to the majors on August 6, 2025, after a challenging minor league stint where he went 4-17 with a 5.47 ERA. His comeback was impressive, pitching 4 1/3 scoreless innings against the Athletics and securing his first big league win on August 16 against Philadelphia.
And this is the part most people miss: While Cavalli’s case is settled, 17 other players are still headed to arbitration hearings from January 26 to February 13 in Scottdale, Arizona. Among them is Tarik Skubal, the two-time AL Cy Young Award winner, who’s asking for a record-breaking $32 million—while the Detroit Tigers are offering just $19 million. Talk about a gap! This raises a thought-provoking question: Are star players like Skubal being undervalued, or are teams rightfully cautious about long-term commitments? What do you think? Let’s hear your take in the comments!
